Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets

Copyright © 2022 Zi, Gao, Du, Xu, Niu and Chi..

Hepatitis Delta Virus (HDV) is the smallest mammalian single-stranded RNA virus. It requires host cells and hepatitis B virus (HBV) to complete its unique life cycle. The present review summarizes the specific regions on hepatitis D antigen (HDAg) and hepatitis B surface antigen (HBsAg) that drive HDV to utilize host cell machinery system to produce three types of RNA and two forms of HDAg, and hijack HBsAg for its secretion and de novo entry. Previously, interferon-α was the only recommended therapy for HDV infection. In recent years, some new therapies targeting these regions, such as Bulevirtide, Lonafarnib, Nucleic acid polymers have appeared, with better curative effects and fewer adverse reactions.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Frontiers in microbiology - 13(2022) vom: 15., Seite 838382

Sprache:

Englisch

Beteiligte Personen:

Zi, Jun [VerfasserIn]
Gao, Xiuzhu [VerfasserIn]
Du, Juan [VerfasserIn]
Xu, Hongqin [VerfasserIn]
Niu, Junqi [VerfasserIn]
Chi, Xiumei [VerfasserIn]

Links:

Volltext

Themen:

Antigen
Hepatitis delta virus
Journal Article
Review
Single-stranded RNA
Therapy
Viral structures
Virus life cycle

Anmerkungen:

Date Revised 16.07.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.3389/fmicb.2022.838382

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339940441